Aperio Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$2.05M Buy
38,326
+6,100
+19% +$326K 0.01% 1224
2020
Q3
$1.33M Sell
32,226
-857
-3% -$35.4K ﹤0.01% 1303
2020
Q2
$1.6M Buy
33,083
+3,262
+11% +$158K 0.01% 1205
2020
Q1
$1.26M Buy
29,821
+1,868
+7% +$78.9K 0.01% 1209
2019
Q4
$1.2M Buy
27,953
+3,385
+14% +$145K ﹤0.01% 1343
2019
Q3
$884K Buy
24,568
+3,184
+15% +$115K ﹤0.01% 1459
2019
Q2
$572K Buy
21,384
+4,127
+24% +$110K ﹤0.01% 1708
2019
Q1
$463K Buy
17,257
+1,339
+8% +$35.9K ﹤0.01% 1791
2018
Q4
$257K Buy
15,918
+239
+2% +$3.86K ﹤0.01% 2018
2018
Q3
$325K Sell
15,679
-907
-5% -$18.8K ﹤0.01% 1969
2018
Q2
$253K Sell
16,586
-1,007
-6% -$15.4K ﹤0.01% 2072
2018
Q1
$395K Sell
17,593
-633
-3% -$14.2K ﹤0.01% 1808
2017
Q4
$549K Buy
18,226
+195
+1% +$5.87K ﹤0.01% 1658
2017
Q3
$679K Buy
18,031
+279
+2% +$10.5K ﹤0.01% 1505
2017
Q2
$495K Sell
17,752
-3,199
-15% -$89.2K ﹤0.01% 1667
2017
Q1
$720K Buy
20,951
+263
+1% +$9.04K ﹤0.01% 1333
2016
Q4
$597K Buy
20,688
+2,131
+11% +$61.5K ﹤0.01% 1413
2016
Q3
$590K Buy
18,557
+760
+4% +$24.2K ﹤0.01% 1358
2016
Q2
$578K Sell
17,797
-1,167
-6% -$37.9K ﹤0.01% 1314
2016
Q1
$530K Buy
18,964
+4,335
+30% +$121K ﹤0.01% 1333
2015
Q4
$522K Buy
14,629
+769
+6% +$27.4K ﹤0.01% 1319
2015
Q3
$458K Sell
13,860
-296
-2% -$9.78K ﹤0.01% 1347
2015
Q2
$593K Buy
14,156
+5,290
+60% +$222K 0.01% 1232
2015
Q1
$289K Buy
8,866
+93
+1% +$3.03K ﹤0.01% 1596
2014
Q4
$279K Buy
+8,773
New +$279K ﹤0.01% 1550
2014
Q2
Sell
-8,421
Closed -$205K 1734
2014
Q1
$205K Buy
+8,421
New +$205K ﹤0.01% 1851
2013
Q4
Sell
-7,986
Closed -$219K 1983
2013
Q3
$219K Buy
+7,986
New +$219K ﹤0.01% 1596